LAKE FOREST, IL, United States
HOSPIRA INC, LAKE FOREST recalls
1 recall recorded since 2018, most recently on 4 June 2018. None are listed as ongoing. Status and classification are as published by the FDA.
Recalls1
Ongoing (FDA)0
Terminated or completed1
Class I (FDA)1
Terminated Class I Drugs
- Recall started
- 4 June 2018
- Terminated
- 27 March 2020
- Reason
- Presence of Particulate Matter; Potential for particulate matter on the syringe plunger.
- Distribution
- Nationwide in the U.S., Puerto Rico, and Guam
- Initiated
- Voluntary: Firm initiated
- Recall number
- D-0906-2018
- Naloxone Hydrochloride Injection, USP, 0.4 mg/mL, 1 mL in 2.5 mL Carpuject Single-use cartridge syringe, Single unit (NDC 0409-1782-03) and 10 count box (NDC 0409-1782-69), Rx Only, Hospira Inc., Lake Forest, IL
A terminated FDA recall means the FDA has determined that all reasonable efforts to remove or correct the product have been made. What statuses mean.